Product Features 5mg BPC-157 peptide per vial Lyophilised powder format Research grade material Sealed laboratory vial Tamper evident cap Individually batch coded For laboratory research use only Product Specification Storage Instructions Store refrigerated between 2C and 8C Keep vial sealed until use Protect from heat, moisture, and direct sunlight Handle only within suitable laboratory conditions Important Notice This product is supplied strictly for laboratory research and analytical purposes only

There are two types of carnitine deficiency: Primary carnitine deficiency A genetic disorder Usually develops by five years of age Symptoms include Disease of the heart muscle (cardiomyopathy) Skeletal-muscle weakness Low blood sugar (hypoglycemia) Secondary carnitine deficiency Caused by other underlying conditions that decrease the amount of carnitine in the body that cause the body to: Increase the amount of carnitine excreted in urine Absorb less carnitine from food Chronic renal failure Use of certain antibiotics Certain medicines, such as valproate Liver disease Digestive disease that causes poor absorption Malnutrition Mitochondrial disease Certain metabolic disorders From Diet and Weight Loss Resources Image source: iStock Images
Without adequate intrinsic factor, the body cannot absorb vitamin B12 from food, leading to pernicious anemia and potentially severe neurological complications
However, participants with obesity did show reductions in heavy drinking
have entered into an exclusive global license agreement for HS-10535, a preclinical oral small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist